Growth Metrics

Travere Therapeutics (TVTX) Liabilities from Discontinued Operations (2022)

Travere Therapeutics (TVTX) has disclosed Liabilities from Discontinued Operations for 1 consecutive years, with 7000000.0 as the latest value for Q4 2022.

  • For the quarter ending Q4 2022, Liabilities from Discontinued Operations changed N/A year-over-year to 7000000.0, compared with a TTM value of 7000000.0 through Dec 2022, changed N/A, and an annual FY2022 reading of 7000000.0, changed N/A over the prior year.
  • Liabilities from Discontinued Operations was 7000000.0 for Q4 2022 at Travere Therapeutics.
  • Across five years, Liabilities from Discontinued Operations topped out at 7000000.0 in Q4 2022 and bottomed at 7000000.0 in Q4 2022.